Randomized Trial: Naproxen vs. Colchicine for the Treatment of Gout Flares in Primary Care
4 Nov, 2019 | 01:13h | UTC
Related Commentary on Twitter
Our @NIHRSPCR funded research finds no diff in pain between people with a #goutflare randomised to either #naproxen or low-dose #colchicine, but #naproxen caused fewer #sideeffects, supporting its use as first-line treatment for #flares in #primarycare https://t.co/cKBDymlFjS
— Inflam Arthr Keele (@KeeleInflamArth) November 1, 2019